Live Quote · NASDAQPRMEHealthcare· Biotechnology

Prime Medicine, Inc.

$3.55▼ 7.55%($-0.29)
MKT CAP $645.82MNEXT EARNINGS Mar 2, 2027
50%
Bullish
TickerSpark Score
55/100
▌ Mixed
20
Valuation
35
Profitability
95
Growth
64
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PRME research report →

Analyst Price Target
$7.50+111.3% vs. today

Range $6 – $9

Analyst RatingBuy
7 Buy3 Hold0 Sell

Price Chart

+3.23% · this period
$5.36$4.03$2.70Nov 19May 22Nov 19
52-Week Range27% of range
Low
$2.67
Current
$3.55
High
$5.91